Pharmaceutical promotion and first amendment rights

New England Journal of Medicine

Volumn 359, Issue 5, 2008, Pages 536-537

  Troy, Daniel E ^a   Gottlieb, Scott ^b  

^a SIDLEY AUSTIN LLP   (United States)

^b AMERICAN ENTERPRISE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COURT; DRUG MARKETING; GOVERNMENT; LETTER; MEDICAL INFORMATION; OFF LABEL DRUG USE; PATIENT CARE; PRIORITY JOURNAL; UNITED STATES;

EID: 48249100463     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc081122     Document Type: Letter

References (4)

1. Kesselheim AS, Avorn J. Pharmaceutical promotion to physicians and First Amendment rights. N Engl J Med 2008;358:1727-32.
2. Cincinnati v. Discovery Network, 507 U.S. 410 (1993).
3. Edenfield v. Fane, 507 U.S. 761 (1993).
4. Ibanez v. Florida Dept. of Business & Professional Regulation, 512 U.S. 136 (1994).